Enlivex Therapeutics Ltd. (FRA:1BT)
Germany · Delayed Price · Currency is EUR 0.7050
+0.0150 (2.17%)
Last updated: Jan 9, 2026, 8:02 AM CET
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of €184.02 million as of January 9, 2026. Its market cap has increased by 601.67% in one year.
Market Cap
184.02M
Enterprise Value
168.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.70
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has increased from 90.03M to 184.02M, an increase of 104.38%. That is a compound annual growth rate of 11.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 184.02M | 29.43% |
| Dec 31, 2025 | 142.17M | 472.11% |
| Dec 31, 2024 | 24.85M | -45.30% |
| Dec 29, 2023 | 45.43M | -33.03% |
| Dec 30, 2022 | 67.83M | -32.66% |
| Dec 31, 2021 | 100.74M | 1.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |